Viagra’s Fight Against Pharmaceutical Counterfeiting By Rands Joseph At Isnare.com Ezine Articles

Viagra is the savior of erectile dysfunction (ED) sufferers. Its immense health benefit rendered to ED sufferers is responsible for its mounting popularity. Since the debut of this drug in the market, its maker Pfizer Inc. is basking in its glory. But due to its unparallel popularity, it has become the target of some cheap drug and unlawful drug makers who’re making huge chunk of money by manufacturing fake Viagra.

Pharmaceutical counterfeiting is on the rise, with the number of cases investigated by the FDA jumping to 58 in 2005 from six in 2000. According to the World Health Organization, it is estimated that $35 billion worth of counterfeit drugs are sold each year. To tackle this rising problem the U.S. Food and Drug Administration is urging drugmakers to use electronic tagging technology to improve the safety and supply of medicines for its users.

The counterfeiting business is costing Pfizer millions of dollars and to get rid off this problem, the is adding electronic identification tags to U.S. shipments of its impotence treatment Viagra as a way to stop fake copies of the world's most counterfeited drug. Pfizer is using the technology commonly known as radio-frequency identification, to link each package, case and pallet of Viagra to a unique electronic code so that wholesalers and pharmacies can be assured about the authenticity of the product.

This technology will be used on an experiment basis and if it works then Pfizer, the world's biggest drug maker, may expand use of the tags to other products for avoiding further counterfieting. It will be a big sigh of relief for millions of drug users worldwide as fake or counterfeit drugs can be extremely injurious to health. So, next time onwards while buying Viagra, refer to the electronic identification tag for avoiding fake drugs.

Published At: Isnare Free Articles Directory http://www.isnare.com
Permanent Link: http://www.isnare.com/?aid=28187&ca=Sexuality

Important Notice DISCLAIMER: All information, content, and data in this article are sole opinions and/or findings of the individual user or organization that registered and submitted this article at Isnare.com without any fee. The article is strictly for educational or entertainment purposes only and should not be used in any way, implemented or applied without consultation from a professional. We at Isnare.com do not, in anyway, contribute or include our own findings, facts and opinions in any articles presented in this site. Publishing this article does not constitute Isnare.com's support or sponsorship for this article. Isnare.com is an article publishing service. Please read our Terms of Service for more information.